OPTIMAL DOSAGE OF PRO-LEU-GLY-NH2 (MIF) IN NEUROPHARMACOLOGICAL TESTS AND CLINICAL USE

被引：29

作者：

BJORKMAN, S ^{[1
]}

SIEVERTSSON, H ^{[1
]}

机构：

[1] UNIV UPPSALA,CTR BIOMED,DEPT ORGAN PHARMACEUT CHEM,S-75123 UPPSALA,SWEDEN

来源：

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1977年 / 298卷 / 02期

关键词：

D O I：

10.1007/BF00508614

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：79 / 81

页数：3

共 17 条

[1]

BARBEAU A, 1976, CAN MED ASSOC J, V114, P120

[2]

BJORKMAN S, 1976, ACTA PHARM SUEC, V13, P289

[3] STUDIES ON INHIBITION OF OXOTREMORINE INDUCED TREMOR BY A MELANOCYTE-STIMULATING HORMONE RELEASE-INHIBITING FACTOR, THYROTROPIN RELEASING HORMONE AND RELATED PEPTIDES [J].

CASTENSSON, S ;

SIEVERTSSON, H ;

LINDEKE, B ;

SUM, CY .

FEBS LETTERS, 1974, 44 (01) :101-105

[4] THE UP-AND-DOWN METHOD FOR SMALL SAMPLES [J].

DIXON, WJ .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1965, 60 (312) :967-978

[5] EFFECT OF MELANOCYTE-STIMULATING HORMONE-RELEASE INHIBITING FACTOR (MIF) IN PARKINSONS SYNDROME [J].

FISCHER, PA ;

SCHNEIDER, E ;

JACOBI, P ;

MAXION, H .

EUROPEAN NEUROLOGY, 1974, 12 (5-6) :360-368

[6]

FRIEDMAN AJ, 1973, SCIENCE, V182, P831

[7]

GERSTENBRAND F, 1975, WIEN KLIN WOCHENSCHR, V87, P822

[8] INTENSIFICATION OF CENTRAL CATECHOLAMINERGIC AND SEROTONERGIC PROCESSES BY HYPOTHALAMIC FACTORS MIF AND TRF AND BY ANGIOTENSIN-II [J].

HUIDOBROTORO, JP ;

SCOTTIDECAROLIS, A ;

LONGO, VG .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1975, 3 (02) :235-242

[9]

KASTIN AJ, 1972, CAN MED ASSOC J, V107, P1079

[10] ALPHA-MSH AND MIF-I EFFECTS ON CATECHOLAMINE LEVELS AND SYNTHESIS IN VARIOUS RAT-BRAIN AREAS [J].

KOSTRZEWA, RM ;

KASTIN, AJ ;

SPIRTES, MA .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1975, 3 (06) :1017-1023

← 1 2 →